This inventor holds 1 USPTO granted patent. Top assignees: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Otsuka Pharmaceutical Factory, Inc., The University of Tokyo. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2015
Title: Yuiichi Tei: Innovator in Tissue Adhesion Prevention
Introduction
Yuiichi Tei is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the area of tissue adhesion prevention. His innovative approach aims to enhance surgical outcomes and patient safety.
Latest Patents
Yuiichi Tei holds a patent for a solution designed for tissue adhesion prevention. The patent, titled "Solution for tissue adhesion prevention and method for tissue adhesion prevention," focuses on providing a stable and convenient covering condition during surgery. The active ingredient in this solution is trehalose, which is complemented by a range of additional components, including antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and various polysaccharides. This solution can be administered in multiple forms, such as perfusion fluid, spray fluid, or injection solution for intravenous fluids.
Career Highlights
Throughout his career, Yuiichi Tei has worked with prominent organizations, including Otsuka Pharmaceutical Factory, Inc. and The University of Tokyo. His experience in these institutions has allowed him to develop and refine his innovative solutions in the medical field.
Collaborations
Yuiichi Tei has collaborated with esteemed colleagues, including Yoshikatsu Miwa and Shigeki Suzuki. These partnerships have contributed to the advancement of his research and the successful development of his patented solutions.
Conclusion
Yuiichi Tei's work in tissue adhesion prevention showcases his commitment to improving surgical practices and patient care. His innovative solutions have the potential to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile